|
Volumn 5, Issue 4, 2004, Pages 231-233
|
Metformin extended release - DepoMed: Metformin, metformin, gastric retention, metformin GR
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLIBENCLAMIDE;
GLYCOSYLATED HEMOGLOBIN;
METFORMIN;
METFORMIN GR;
UNCLASSIFIED DRUG;
ARTICLE;
ASIA;
CANADA;
CLINICAL TRIAL;
CONTROLLED RELEASE FORMULATION;
COOPERATION;
DIARRHEA;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
EUROPE;
GASTROINTESTINAL DISEASE;
HEADACHE;
HEMOGLOBIN DETERMINATION;
HUMAN;
LICENCE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
PROSPECTIVE PAYMENT;
SUSTAINED RELEASE FORMULATION;
TASTE DISORDER;
UNITED STATES;
DELAYED-ACTION PREPARATIONS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 4143061374
PISSN: 11745886
EISSN: None
Source Type: Journal
DOI: 10.2165/00126839-200405040-00009 Document Type: Article |
Times cited : (7)
|
References (5)
|